Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on DIM. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN108473451A reveals metal-free synthesis for high-purity pharmaceutical intermediates. Achieve significant cost reduction and supply chain reliability.
Patent CN103641686A reveals a novel synthesis for 2,3,5,6-tetrafluoro-1,4-benzenedimethanol, offering cost reduction in agrochemical manufacturing and enhanced supply reliability.
Patent CN104341342A reveals ethanol-based DAST synthesis yielding 95% purity. Offers supply chain stability and cost reduction for optoelectronic manufacturing.
Patent CN114249668B reveals safer PPTS catalysis for Zolpidem intermediate. Enhances supply chain reliability and reduces manufacturing costs significantly.
Novel two-step copper-catalyzed route for azabicyclo hexanone. Reduces cost and improves supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN104926674B details a novel route for Z-unsaturated amides offering safer processing and reduced waste for global pharmaceutical intermediate supply chains.
Novel synthetic route for 7-chloro-2,2-dimethylheptanoate using 1-bromo-5-chloropentane. Achieves high purity, minimizes byproducts, and enables scalable manufacturing for lipid-lowering APIs.
Patent CN100564365C details a streamlined 2-step synthesis for Anastrozole, offering superior purity and cost efficiency for pharmaceutical manufacturing.
Novel patent CN103864588B offers eco-friendly synthesis. Reduces toxicity, improves yield for reliable pharmaceutical intermediate supply chains.
Patent CN112778351B details a ligand-free, green synthesis of beta-dimethylphenyl silicon substituted aromatic nitro compounds using recyclable cellulose-supported copper nanoparticles.
Patent CN101628889A reveals a high-yield toluene-based route for Donepezil key intermediates, offering significant cost and purity advantages for API manufacturers.
Novel synthesis patent CN118255679A offers high yield and safety. Reduces toxic reagents for reliable pharmaceutical intermediate supply chain stability.
Novel patent CN119306612A enables high trans-selectivity. Reduces waste and cost for pharmaceutical intermediate manufacturing supply chains.
Advanced preparation of 2-(2-aminoethoxy)-1,1-dimethoxyethane via CN113527119A. Offers high purity, simplified isolation, and cost-effective manufacturing for influenza drug supply chains.
Patent CN104262122B reveals metal-free synthesis. Offers cost reduction and supply reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN102120731A reveals a novel, high-yield route for Gefitinib intermediates, offering significant cost reduction and simplified purification for pharmaceutical manufacturing.
Novel patent CN119263959B details cost-effective 1,2-cyclopentanedimethanol production. Enhances supply chain reliability and reduces manufacturing complexity for pharmaceutical intermediates.
Patent CN112812032A reveals a green route to acetamides using dimethyl carbonate, offering cost-effective solutions for pharmaceutical intermediate manufacturing.
Patent CN101781222A details a mild sodium-mediated route for enaminones, offering cost-effective manufacturing and high purity for pharmaceutical supply chains.
Novel chiral induction method for Paxlovid intermediate. Reduces cost and improves safety. Reliable supply chain partner for pharmaceutical manufacturing.